Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven K Libutti

Showing results (71-80 of 222) with videos related to

Pageof 23
Sort By:
The Journal of Clinical Endocrinology and Metabolism|June 28, 2012
Development and treatment of tertiary hyperparathyroidism in patients with pseudohypoparathyroidism type 1BNicola M Neary, Diala El-Maouche, Rachel Hopkins, et al.
Journal of the American College of Surgeons|September 14, 2022
Association of Implementation of Operating Room-Based Parathyroid Hormone Testing with Operative Time and CostSteven Xie, Jonathan Kuriakose, Toni Beninato, et al.
Current Problems in Surgery|October 24, 2006
Islet cell tumorsElizabeth A Mittendorf, Alexander L Shifrin, William B Inabnet, et al.
Annals of Surgical Oncology|November 4, 2011
What is the best criterion for the interpretation of adrenal vein sample results in patients with primary hyperaldosteronism?Richard Webb, Aarti Mathur, Richard Chang, et al.
Cell Reports|March 17, 2021
Amino acids-Rab1A-mTORC1 signaling controls whole-body glucose homeostasisXin Zhang, Xiaowen Wang, Ziqiang Yuan, et al.
Cancer|September 5, 2002
Hepatic vascular isolation and perfusion for patients with progressive unresectable liver metastases from colorectal carcinoma refractory to previous systemic and regional chemotherapyH Richard Alexander, Steven K Libutti, David L Bartlett, et al.
Cancer Research|September 18, 2004
Proadrenomedullin NH2-terminal 20 peptide is a potent angiogenic factor, and its inhibition results in reduction of tumor growthAlfredo Martínez, Enrique Zudaire, Sergio Portal-Núñez, et al.
Lancet (London, England)|April 9, 2004
Insulinomas and expression of an insulin splice variantAlexandra H Minn, Mark Kayton, Dominique Lorang, et al.
Endocrinology|June 18, 2010
Multiple endocrine neoplasia type 1 deletion in pancreatic alpha-cells leads to development of insulinomas in miceH-C Jennifer Shen, Kris Ylaya, Klaus Pechhold, et al.
Surgery|December 20, 2005
A six-gene model for differentiating benign from malignant thyroid tumors on the basis of gene expressionJennifer Rosen, Mei He, Christopher Umbricht, et al.
Pageof 23

Showing results (71-80 of 222) with videos related to

Sort By:
Pageof 23
The Journal of Clinical Endocrinology and Metabolism|June 28, 2012
Development and treatment of tertiary hyperparathyroidism in patients with pseudohypoparathyroidism type 1BNicola M Neary, Diala El-Maouche, Rachel Hopkins, et al.
Journal of the American College of Surgeons|September 14, 2022
Association of Implementation of Operating Room-Based Parathyroid Hormone Testing with Operative Time and CostSteven Xie, Jonathan Kuriakose, Toni Beninato, et al.
Current Problems in Surgery|October 24, 2006
Islet cell tumorsElizabeth A Mittendorf, Alexander L Shifrin, William B Inabnet, et al.
Annals of Surgical Oncology|November 4, 2011
What is the best criterion for the interpretation of adrenal vein sample results in patients with primary hyperaldosteronism?Richard Webb, Aarti Mathur, Richard Chang, et al.
Cell Reports|March 17, 2021
Amino acids-Rab1A-mTORC1 signaling controls whole-body glucose homeostasisXin Zhang, Xiaowen Wang, Ziqiang Yuan, et al.
Cancer|September 5, 2002
Hepatic vascular isolation and perfusion for patients with progressive unresectable liver metastases from colorectal carcinoma refractory to previous systemic and regional chemotherapyH Richard Alexander, Steven K Libutti, David L Bartlett, et al.
Cancer Research|September 18, 2004
Proadrenomedullin NH2-terminal 20 peptide is a potent angiogenic factor, and its inhibition results in reduction of tumor growthAlfredo Martínez, Enrique Zudaire, Sergio Portal-Núñez, et al.
Lancet (London, England)|April 9, 2004
Insulinomas and expression of an insulin splice variantAlexandra H Minn, Mark Kayton, Dominique Lorang, et al.
Endocrinology|June 18, 2010
Multiple endocrine neoplasia type 1 deletion in pancreatic alpha-cells leads to development of insulinomas in miceH-C Jennifer Shen, Kris Ylaya, Klaus Pechhold, et al.
Surgery|December 20, 2005
A six-gene model for differentiating benign from malignant thyroid tumors on the basis of gene expressionJennifer Rosen, Mei He, Christopher Umbricht, et al.
Pageof 23